| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/05/2008 | CN100372855C 7-imino derivatives of camptothecin having antitumor activity |
| 03/05/2008 | CN100372852C Synthesis of temozolomide and analogs |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372837C Substituted piperidines as novel MDM2-p53 inhibitors |
| 03/05/2008 | CN100372817C Total triterpenoid extract fine thim asterium sponge and its preparation process and application thereof |
| 03/05/2008 | CN100372571C Chitosan-immune RNA composite formulation and preparation method thereof |
| 03/05/2008 | CN100372570C Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastsis or preventing the recurrence of maligant tumor |
| 03/05/2008 | CN100372569C Dendrimer-photosensitizer complexes for medical applications |
| 03/05/2008 | CN100372568C Application of compound MG 132 in preparation of medicine for treating leucocythemia |
| 03/05/2008 | CN100372539C Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol |
| 03/05/2008 | CN100372528C Ginkgolide B soft capsule and its preparing method |
| 03/04/2008 | US7339089 Transgenic cell comprising human leukocyte antigen binding peptide for use as tools diagnosis, prevention and treatment of cell proliferative disorders; genetic vaccines |
| 03/04/2008 | US7339061 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7339031 Cancer therapeutics; inhibits protein synthesis on ribosomes |
| 03/04/2008 | US7339027 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7338966 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 03/04/2008 | US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent |
| 03/04/2008 | US7338958 Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents |
| 03/04/2008 | US7338957 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 03/04/2008 | US7338946 Indazolium trans-[tetrachlorobis(1H-indazol)-ruthenate(III)]; easily water-soluble; exhibits a high effectiveness in the treatment of cancer illnesses |
| 03/04/2008 | US7338929 Cancer immunotherapy |
| 03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 03/04/2008 | US7338662 Recombinant poxvirus expressing homologous genes inserted into the foxviral genome |
| 03/04/2008 | US7338660 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 |
| 03/04/2008 | US7338659 Reducing immunogenicities of immunoglobulins by framework-patching |
| 03/04/2008 | US7338658 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 03/01/2008 | CA2598060A1 Methods and compositions for the treatment and prevention of cancer |
| 03/01/2008 | CA2597840A1 Methods and compositions for the treatment and prevention of cancer |
| 02/28/2008 | WO2008024981A1 Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 02/28/2008 | WO2008024974A1 Pyrimidine and pyrazine derivatives |
| 02/28/2008 | WO2008024963A1 Benzene, pyridine, and pyridazine derivatives |
| 02/28/2008 | WO2008024961A1 Dihydropyridazine, tetrahydropyridine, chromanone, and dihydronaphthalenone derivatives as heat-shock protein 90 inhibitors |
| 02/28/2008 | WO2008024725A1 Aza-benzofuranyl compounds and methods of use |
| 02/28/2008 | WO2008024724A1 Aza-benzothiophenyl compounds and methods of use |
| 02/28/2008 | WO2008024484A1 Methods and compositions for treating cancer |
| 02/28/2008 | WO2008024439A2 4-aminoquinazoline derivatives and methods of use thereof |
| 02/28/2008 | WO2008024305A2 Bis (thiohydrazide amides) for treating melanoma |
| 02/28/2008 | WO2008024304A2 Compounds for treatment of proliferative disorders |
| 02/28/2008 | WO2008024303A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2008024301A2 Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma |
| 02/28/2008 | WO2008024299A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 02/28/2008 | WO2008024026A2 Use of 9-oxoacridine-10-acetic acid, its salts and esters for the treatment, prophylaxis or relapse prevention of prostate cancer |
| 02/28/2008 | WO2008023818A1 Fiber and method for production of fiber |
| 02/28/2008 | WO2008023725A1 Preventive and/or therapeutic agent for peripheral neuropathy |
| 02/28/2008 | WO2008023698A1 Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 02/28/2008 | WO2008023662A1 Bacterial strain having immunostimulating activity, and beverage, food and immunostimulating agent comprising the bacterial strain |
| 02/28/2008 | WO2008023572A1 Chimeric adenovirus, method for producing the same and pharmaceutical using the same |
| 02/28/2008 | WO2008023364A1 Inhibition of ornithine aminotransferase for the treatment of proliferative disorders |
| 02/28/2008 | WO2008023362A2 Use of a combination of methotrexate and an a3ar agonist for the treatment of cancer |
| 02/28/2008 | WO2008023180A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/28/2008 | WO2008023159A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/28/2008 | WO2008022747A1 Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 02/28/2008 | WO2008022535A1 A pharmaceutical composition for treating brain glioma, its process and pharmaceutical preparation |
| 02/28/2008 | WO2008022505A1 Use of rubescensine a and derivatives thereof in pharmacy |
| 02/28/2008 | WO2008022396A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 02/28/2008 | WO2008009335A3 Aminoindazole urea derivatives |
| 02/28/2008 | WO2008007123A3 Pharmaceutical compounds |
| 02/28/2008 | WO2008006883A3 Benzopyranopyrazoles |
| 02/28/2008 | WO2008006113A3 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 02/28/2008 | WO2008003013A3 Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic |
| 02/28/2008 | WO2007139967A3 Triazole compounds that modulate hsp90 activity |
| 02/28/2008 | WO2007136592A3 2-0x0-l,2-dihydr0quin0line derivatives, compositions, and uses thereof as antiproliferative agents |
| 02/28/2008 | WO2007084670A8 Specific therapy using integrin ligands for treating cancer |
| 02/28/2008 | WO2007069090A3 Cell penetrating peptides for intracellular delivery of molecules |
| 02/28/2008 | WO2007045959A3 Antioxidant and fe2+chelating properties of herbal extracts |
| 02/28/2008 | WO2007016095A3 Cyclooxygenase-2 selective inhibitor compounds comprising nitric oxide enhancing groups, compositions and methods of use |
| 02/28/2008 | US20080051466 Isoalpha acid based protein kinase modulation cancer treatment |
| 02/28/2008 | US20080051465 Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment |
| 02/28/2008 | US20080051464 Protein phosphatase inhibitors |
| 02/28/2008 | US20080051463 Anthracene compounds and their use for treating benign and malignant tumor disorders |
| 02/28/2008 | US20080051462 Methods for treating genetically-defined proliferative disorders with HSP90 inhibitors |
| 02/28/2008 | US20080051450 Process For The Preparation Of Anhydrous And Hydrated Active Pharmaceutical Ingredients (Apis); Stable Pharmaceutical Compositions Prepared From The Same And Uses Of Said Compositions |
| 02/28/2008 | US20080051442 Agent for prevention and treatment of cancer comprising oxadiazole urea compound obstructing activity of stat |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051431 Methods and compositions using immunomodulatory compounds in combination therapy |
| 02/28/2008 | US20080051423 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/28/2008 | US20080051422 4-Aminoquinazoline derivatives and methods of use thereof |
| 02/28/2008 | US20080051419 Amine derivatives useful as anticancer agents |
| 02/28/2008 | US20080051414 Protein Kinase Inhibitors |
| 02/28/2008 | US20080051412 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds and their Uses |
| 02/28/2008 | US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents |
| 02/28/2008 | US20080051404 Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 02/28/2008 | US20080051402 Method of inhibiting c-kit kinase |
| 02/28/2008 | US20080051401 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer |
| 02/28/2008 | US20080051398 Method of treating brain cancer |
| 02/28/2008 | US20080051397 with polyglycolized glyceride (macrogol glyceride); Gelucires"; multiple sclerosis, asthma, scleroderma, endometriosis; 1,3-benzothiazol-2(3H)-ylidene{2-[(1,4-dimethylpiperazin-2-yl)methoxy]pyrimidin-4-yl}acetonitrile; adding to melt as powder under stirring resulting in homogeneous molten dispersion |
| 02/28/2008 | US20080051395 2-Pyrimidinyl Pyrazolopyridine Erbb Kinase Inhibitors |
| 02/28/2008 | US20080051389 mimetics of the Smac peptide, used for the treatment of cancer and autoimmune disorders |
| 02/28/2008 | US20080051380 Methods and compositions for treating cancer |
| 02/28/2008 | US20080051379 Compositions and Methods for the Treatment of Peripheral B-Cell Neoplasms |
| 02/28/2008 | US20080051376 Method for Producing Albumin-Corticoid Conjugates |
| 02/28/2008 | US20080051375 Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same |
| 02/28/2008 | US20080051370 Ruthenium Complexes For Treating Cancers |
| 02/28/2008 | US20080051359 Antisense oligonucleotide modulation of stat3 expression |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051349 Peptide antagonists of zonulin and methods for use of the same |